B

Bright Minds Biosciences
DRUG

Last Price

Financial Snapshot

gainify

Market Data

Market Cap
CA$307.54M
EV
CA$249.83M
Shares Outstanding
7.65M
Beta
1.02

Wall Street View

Analyst Rating
BUY
Analyst Target Price
CA$80.00
P/E 2025E
-
P/Revenue 2025E
-

Price Dynamic

Price

%

1M

3M

6M

1Y

3Y

5Y

Peers

gainify

About Bright Minds Biosciences Inc.

gainify

B

Bright Minds Biosciences Inc.

DRUG

Bright Minds Biosciences Inc., a biotechnology company, develops therapeutics to improve the lives of patients with severe and life-altering diseases in the United States. Its portfolio of selective 5-HT receptor agonists includes 5-HT2C, 5-HT2A, and 5-HT2C/A for the ...

Sector

Healthcare

Industry

Biotechnology

CEO

McDonald, Ian

Employees

IPO Date

2021-02-09

Headquarters

19 Vestry Street, New York, New York, 10013, United States

gainify
mailcontactcontact
powered-by-sp

NEWSLETTER

COMPANY

© Copyright 2025, All Rights Reserved